KAYLEIGH LAND: Open Payments
NPI 1801325584 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 26 payments from 20 companies in 2025. Trend: 2023 $195 · 2024 $400 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $67 |
| Xeris Pharmaceuticals, Inc. | 3 | $53 |
| CeQur Corporation | 1 | $40 |
| Sequel Med Tech, LLC | 2 | $35 |
| Medtronic, Inc. | 2 | $29 |
| Madrigal Pharmaceuticals | 1 | $27 |
| BETA BIONICS, INC. | 1 | $27 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $23 |
Products named: FREESTYLE LIBRE 3, CeQur Simplicity, TWIIST, GVOKE HYPOPEN, INPEN SMART INSULIN DELIVERY SYSTEM, REZDIFFRA, iLet Bionic Pancreas, CRENESSITY.
Industry payments across IN — which companies pay providers there.
